{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:19:51Z","timestamp":1787923191950,"version":"build-2784847793"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clinimag.2026.110877","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T06:14:02Z","timestamp":1781936042000},"page":"110877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lipiodol in embolization therapy: Evolution from a diagnostic to a therapeutic agent"],"prefix":"10.1016","volume":"137","author":[{"given":"Areeb","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Epelboym","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedros","family":"Taslakian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Casadaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Bent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Guermazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh P.","family":"Krishnasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"305","key":"10.1016\/j.clinimag.2026.110877_bb0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3406\/pharm.1995.4238","article-title":"The history of lipiodol (1901-1994) or how a medication may evolve with the times","volume":"42","author":"Bonnemain","year":"1995","journal-title":"Rev Hist Pharm (Paris)"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110877_bb0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jvir.2010.10.030","article-title":"Lipiodol = ethiodol","volume":"22","author":"Kolbeck","year":"2011","journal-title":"J Vasc Interv Radiol"},{"issue":"10","key":"10.1016\/j.clinimag.2026.110877_bb0015","article-title":"Clinical uses and short-term safety profile of ethiodized poppy seed oil contrast agent in the diagnosis and treatment of vascular anomalies and tumors","volume":"11","author":"Clemens","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"325","key":"10.1016\/j.clinimag.2026.110877_bb0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3406\/pharm.2000.5041","article-title":"Lipiodol therapeutic indications from 1901 to 1930","volume":"48","author":"Bonnemain","year":"2000","journal-title":"Rev Hist Pharm (Paris)"},{"key":"10.1016\/j.clinimag.2026.110877_bb0030","first-page":"1264","article-title":"Methode radiographique d\u2019exploration de la cavite epidurale par le lipiodol","volume":"37","author":"Sicard","year":"1921","journal-title":"Rev Neurol"},{"key":"10.1016\/j.clinimag.2026.110877_rf0035","first-page":"13","article-title":"Lymphangiography in man. A method of outlining lymphatic trunks at operation","volume":"2","author":"Kinmonth","year":"1952","journal-title":"Clin Sci"},{"key":"10.1016\/j.clinimag.2026.110877_rf0040","first-page":"300","article-title":"Lymphangiography in clinical surgery and particularly in the treatment of lymphoedema","volume":"15","author":"Kinmonth","year":"1954","journal-title":"Ann R Coll Surg Engl"},{"issue":"9","key":"10.1016\/j.clinimag.2026.110877_bb0040","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/RLI.0000000000000578","article-title":"Back to the future: lipiodol in lymphography\u2014from diagnostics to theranostics","volume":"54","author":"Pieper","year":"2019","journal-title":"Invest Radiol"},{"issue":"5","key":"10.1016\/j.clinimag.2026.110877_bb0045","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"issue":"9319","key":"10.1016\/j.clinimag.2026.110877_bb0050","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clinimag.2026.110877_bb0055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clinimag.2026.110877_bb0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/curroncol31040154","article-title":"Liver-directed locoregional therapies for neuroendocrine liver metastases: recent advances and management","volume":"31","author":"Criss","year":"2024","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clinimag.2026.110877_bb0065","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00261-017-1267-4","article-title":"Safety and efficacy of transcatheter embolization with Glubran\u00ae 2 cyanoacrylate glue for acute arterial bleeding: a single-center experience with 104 patients","volume":"43","author":"Abdulmalak","year":"2018","journal-title":"Abdom Radiol"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110877_bb0070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.nec.2014.04.009","article-title":"Endovascular approaches to pial arteriovenous malformations","volume":"25","author":"Sanborn","year":"2014","journal-title":"Neurosurg Clin N Am"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110877_bb0075","doi-asserted-by":"crossref","first-page":"475","DOI":"10.17219\/acem\/37149","article-title":"Epidemiology, diagnostics and treatment of vascular tumours and malformations","volume":"23","author":"W\u00f3jcicki","year":"2014","journal-title":"Adv Clin Exp Med"},{"issue":"14","key":"10.1016\/j.clinimag.2026.110877_bb0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/jcm10143161","article-title":"Prostate artery embolization using N-butyl cyanoacrylate glue for urinary tract symptoms due to benign prostatic hyperplasia: a valid alternative to microparticles?","volume":"10","author":"Loffroy","year":"2021","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.clinimag.2026.110877_bb0085","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jvir.2024.07.018","article-title":"Early outcomes of prostatic artery embolization using n-butyl cyanoacrylate liquid embolic agent: a safety and feasibility study","volume":"35","author":"Bamshad","year":"2024","journal-title":"J Vasc Interv Radiol"},{"issue":"8","key":"10.1016\/j.clinimag.2026.110877_bb0090","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/1538574410377123","article-title":"Lymphangiography in the diagnosis, localization, and treatment of a lymphaticopelvic fistula causing chyluria: a case report","volume":"44","author":"Deso","year":"2010","journal-title":"Vasc Endovascular Surg"},{"issue":"1","key":"10.1016\/j.clinimag.2026.110877_bb0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00270-010-0066-x","article-title":"Lymphangiography in the diagnosis and localization of various chyle leaks","volume":"35","author":"Deso","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"4","key":"10.1016\/j.clinimag.2026.110877_bb0100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.diii.2023.12.003","article-title":"Genicular artery embolization for knee osteoarthritis: results of the LipioJoint-1 trial","volume":"105","author":"Sapoval","year":"2024","journal-title":"Diagn Interv Imaging"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110877_bb0105","first-page":"S150","article-title":"Abstract no. 331 embolization for the treatment of heel pain secondary to plantar fasciitis: a pilot study evaluating safety and efficacy using lipiodol as a novel embolic agent","volume":"36","author":"Bagla","year":"2025","journal-title":"J Vasc Interv Radiol"},{"issue":"12","key":"10.1016\/j.clinimag.2026.110877_bb0110","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jvir.2012.08.028","volume":"23","author":"Lin","year":"2012","journal-title":"J Vasc Interv Radiol"},{"issue":"13","key":"10.1016\/j.clinimag.2026.110877_bb0115","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.7150\/thno.32943","article-title":"Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model","volume":"9","author":"van Breugel","year":"2019","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110877_bb0120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.nucmedbio.2012.11.007","article-title":"A comparison of Re-188-MN-16ET-lipiodol and transcatheter arterial chemoembolization in the treatment of hepatoma: an animal study","volume":"40","author":"Lin","year":"2013","journal-title":"Nucl Med Biol"},{"issue":"7","key":"10.1016\/j.clinimag.2026.110877_bb0125","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.nucmedbio.2011.03.005","article-title":"Synthesis and application of 188Re-MN-16ET\/Lipiodol in a hepatocellular carcinoma animal model","volume":"38","author":"Tang","year":"2011","journal-title":"Nucl Med Biol"},{"issue":"6","key":"10.1016\/j.clinimag.2026.110877_bb0130","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s12149-013-0717-5","article-title":"Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma","volume":"27","author":"Huang","year":"2013","journal-title":"Ann Nucl Med"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110877_bb0135","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.critrevonc.2013.07.003","article-title":"Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review","volume":"88","author":"Id\u00e9e","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clinimag.2026.110877_bb0140","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","article-title":"Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies","volume":"30","author":"Marelli","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"4","key":"10.1016\/j.clinimag.2026.110877_bb0145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000129104","article-title":"Effects of intraarterial chemotherapy using the new lipophilic anticancer agent ‘KM2210’ (estradiol-chlorambucil) dissolved in lipiodol on walker 256 carcinosarcoma in Wistar rats – a preliminary report","volume":"22","author":"Egawa","year":"1990","journal-title":"Eur Surg Res"},{"issue":"5","key":"10.1016\/j.clinimag.2026.110877_bb0150","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2214\/ajr.180.5.1801379","article-title":"Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results","volume":"180","author":"Loewe","year":"2003","journal-title":"Am J Roentgenol"},{"issue":"18","key":"10.1016\/j.clinimag.2026.110877_bb0155","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4254\/wjh.v9.i18.808","article-title":"Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma","volume":"9","author":"Song","year":"2017","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.clinimag.2026.110877_bb0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00270-010-0012-y","article-title":"Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?","volume":"34","author":"Liapi","year":"2011","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"5","key":"10.1016\/j.clinimag.2026.110877_bb0165","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/hep.1840190508","article-title":"Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors","volume":"19","author":"Mondazzi","year":"1994","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinimag.2026.110877_bb0170","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1148\/radiology.214.2.r00fe06349","article-title":"Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success\u2014results from a liver transplantation center","volume":"214","author":"Vogl","year":"2000","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.clinimag.2026.110877_bb0175","first-page":"125","article-title":"Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients","volume":"38","author":"Dumortier","year":"2006","journal-title":"Dig Liver Dis"},{"issue":"11","key":"10.1016\/j.clinimag.2026.110877_bb0180","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1365-2036.2012.05089.x","article-title":"Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma","volume":"35","author":"Kim","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.clinimag.2026.110877_bb0185","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.21873\/invivo.12621","article-title":"Lipiodol deposition and washout in primary and metastatic liver tumors after chemoembolization","volume":"35","author":"Nezami","year":"2021","journal-title":"In Vivo"},{"key":"10.1016\/j.clinimag.2026.110877_bb0190","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110877_bb0195","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. conclusions of the Barcelona-2000 EASL Conference","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110877_bb0200","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2214\/AJR.15.14758","article-title":"Conventional ethiodized oil transarterial chemoembolization for treatment of hepatocellular carcinoma: contemporary single-center review of clinical outcomes","volume":"206","author":"Casadaban","year":"2016","journal-title":"Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.clinimag.2026.110877_bb0205","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1159\/000525500","article-title":"Conventional or drug-eluting beads? Randomized controlled study of chemoembolization for hepatocellular carcinoma: JIVROSG-1302","volume":"11","author":"Ikeda","year":"2022","journal-title":"Liver Cancer"},{"key":"10.1016\/j.clinimag.2026.110877_bb0210","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejrad.2018.03.015","article-title":"Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation","volume":"102","author":"Vogl","year":"2018","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110877_bb0215","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejrad.2014.11.034","article-title":"Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver \u2013 the use of imaging biomarkers as predictors of patient survival","volume":"84","author":"Chapiro","year":"2015","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.clinimag.2026.110877_bb0220","first-page":"54","article-title":"Extemporary sclerosing foam according to personal method: experimental clinical data and catheter usage","volume":"1","author":"Tessari","year":"2001","journal-title":"Int Angiol Suppl"},{"issue":"12","key":"10.1016\/j.clinimag.2026.110877_bb0225","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00270-017-1763-5","article-title":"Parameters for stable water-in-oil lipiodol emulsion for liver trans-arterial chemo-eembolization","volume":"40","author":"Deschamps","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.clinimag.2026.110877_bb0230","series-title":"Martin\u2019s Physical Pharmacy and Pharmaceutical Sciences","author":"Sinko","year":"2023"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110877_bb0235","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1148\/radiology.201.3.8939223","article-title":"Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study","volume":"201","author":"De Baere","year":"1996","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.clinimag.2026.110877_bb0240","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00330-015-3855-4","article-title":"Improved stability of lipiodol\u2013drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: proof of concept using idarubicin","volume":"26","author":"Boulin","year":"2016","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.clinimag.2026.110877_bb0245","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00270-017-1616-2","article-title":"Stabilization improves theranostic properties of lipiodol\u00ae-based emulsion during liver trans-arterial chemo-embolization in a VX2 rabbit model","volume":"40","author":"Deschamps","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"19","key":"10.1016\/j.clinimag.2026.110877_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10194320","article-title":"Endovascular use of cyanoacrylate-lipiodol mixture for peripheral embolization: properties, techniques, pitfalls, and applications","volume":"10","author":"Comby","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.clinimag.2026.110877_bb0255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.diii.2023.12.006","article-title":"Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: a six-month outcome analysis in 103 patients","volume":"105","author":"Loffroy","year":"2024","journal-title":"Diagn Interv Imaging"},{"issue":"2","key":"10.1016\/j.clinimag.2026.110877_bb0260","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/157016109787455617","article-title":"Endovascular therapeutic embolisation: an overview of occluding agents and their effects on embolised tissues","volume":"7","author":"Loffroy","year":"2009","journal-title":"CVP"},{"issue":"6","key":"10.1016\/j.clinimag.2026.110877_bb0265","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00270-022-03069-3","article-title":"Prostatic artery embolization for benign prostatic obstruction: single-centre retrospective study comparing microspheres versus n-butyl cyanoacrylate","volume":"45","author":"Salet","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110877_bb0270","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1258\/ar.2010.090356","article-title":"Effectiveness of therapeutic lymphography on lymphatic leakage","volume":"52","author":"Alejandre-Lafont","year":"2011","journal-title":"Acta Radiol"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110877_bb0275","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejcts.2007.11.028","article-title":"A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery","volume":"33","author":"Boffa","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"issue":"12","key":"10.1016\/j.clinimag.2026.110877_bb0280","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.ejrad.2014.09.013","article-title":"Direct lymphangiography as treatment option of lymphatic leakage: indications, outcomes and role in patient\u2019s management","volume":"83","author":"Gruber-Rouh","year":"2014","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.clinimag.2026.110877_bb0285","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jvir.2013.10.011","article-title":"Therapeutic lymphangiography and CT-guided sclerotherapy for the treatment of refractory lymphatic leakage","volume":"25","author":"Kortes","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.clinimag.2026.110877_bb0290","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s00270-007-9026-5","article-title":"Lymphangiography: forgotten tool or rising star in the diagnosis and therapy of postoperative lymphatic vessel leakage","volume":"30","author":"Kos","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"976","key":"10.1016\/j.clinimag.2026.110877_bb0295","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1259\/bjr\/64849421","article-title":"The effectiveness of lymphangiography as a treatment method for various chyle leakages","volume":"82","author":"Matsumoto","year":"2009","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.clinimag.2026.110877_bb0300","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MLG.0b013e31816067b8","article-title":"Thoracic duct embolization: a new treatment for massive leak after neck dissection","volume":"118","author":"Patel","year":"2008","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.clinimag.2026.110877_bb0305","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/j.tvir.2016.10.005","article-title":"Interventional treatment of pulmonary lymphatic anomalies","volume":"19","author":"Itkin","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.clinimag.2026.110877_bb0310","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jvir.2013.09.002","article-title":"Transhepatic lymphatic embolization of intractable hepatic lymphorrhea","volume":"25","author":"Guez","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.clinimag.2026.110877_bb0315","article-title":"Nodal lymphangiography and embolization for postoperative lymphatic leakage","volume":"10","author":"Kariya","year":"2025","journal-title":"Interv Radiol"},{"issue":"9","key":"10.1016\/j.clinimag.2026.110877_bb0320","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jvir.2011.05.003","article-title":"Intranodal lymphangiography: feasibility and preliminary experience in children","volume":"22","author":"Rajebi","year":"2011","journal-title":"J Vasc Interv Radiol"},{"issue":"7","key":"10.1016\/j.clinimag.2026.110877_bb0325","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jvir.2018.02.034","article-title":"Validation of the position of injection needles with contrast-enhanced ultrasound for dynamic contract-enhanced MR lymphangiography","volume":"29","author":"Nadolski","year":"2018","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"10.1016\/j.clinimag.2026.110877_bb0330","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jvir.2012.01.078","article-title":"Feasibility of ultrasound-guided intranodal lymphangiogram for thoracic duct embolization","volume":"23","author":"Nadolski","year":"2012","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"10.1016\/j.clinimag.2026.110877_bb0335","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1148\/rg.2017170014","article-title":"MR lymphangiography in children: technique and potential applications","volume":"37","author":"Chavhan","year":"2017","journal-title":"Radiographics"},{"issue":"21","key":"10.1016\/j.clinimag.2026.110877_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13216432","article-title":"Ultrasound-guided intranodal lipiodol lymphangiography for the assessment and treatment of chylous leaks: a retrospective case series from a single center in Switzerland and a systematic review of the literature","volume":"13","author":"Schulz","year":"2024","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.clinimag.2026.110877_bb0345","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1007\/s00270-014-0888-z","article-title":"Intranodal lymphangiogram: technical aspects and findings","volume":"37","author":"Kariya","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1_suppl","key":"10.1016\/j.clinimag.2026.110877_bb0350","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/15910199000060S129","article-title":"Embolization of arteriovenous malformation with diluted mixture of NBCA","volume":"6","author":"Tamatani","year":"2000","journal-title":"Interv Neuroradiol"},{"issue":"03","key":"10.1016\/j.clinimag.2026.110877_bb0355","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0044-1787785","article-title":"Safety and efficacy of lipiodol and N-butyl cyanoacrylate (N-BCA) combination for vascular embolization","volume":"08","author":"Prasad","year":"2024","journal-title":"J Clin Interv Radiol"},{"issue":"1","key":"10.1016\/j.clinimag.2026.110877_bb0360","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.chphma.2021.09.008","article-title":"Liquid embolic agents for interventional embolization","volume":"1","author":"Jiang","year":"2022","journal-title":"ChemPhysMater"},{"key":"10.1016\/j.clinimag.2026.110877_bb0365","doi-asserted-by":"crossref","DOI":"10.25259\/JCIS_33_2025","article-title":"Percutaneous n-butyl cyanoacrylate glue embolization combined with arterial embolization for extracranial arteriovenous malformations","volume":"15","author":"Tong","year":"2025","journal-title":"J Clin Imaging Sci"},{"issue":"5","key":"10.1016\/j.clinimag.2026.110877_bb0370","first-page":"748","article-title":"N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial","volume":"23","author":"Investigators T n BT","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"10.1016\/j.clinimag.2026.110877_bb0375","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/jcm14062106","article-title":"Genicular artery embolization: a technical review of anatomy, pathophysiology, current experiences, and future directions","volume":"14","author":"Brown","year":"2025","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.clinimag.2026.110877_bb0380","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s00270-024-03860-4","article-title":"Lipiodol! Are musculoskeletal embolizations a rebirth?","volume":"47","author":"Pellerin","year":"2024","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"10.1016\/j.clinimag.2026.110877_bb0385","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/ard.2004.023028","article-title":"Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state","volume":"64","author":"Tubach","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.clinimag.2026.110877_bb0390","first-page":"1648","article-title":"Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set of responder criteria","volume":"30","author":"Pham","year":"2003","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.clinimag.2026.110877_bb0395","doi-asserted-by":"crossref","DOI":"10.1002\/hep.28453","article-title":"Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data","volume":"64","author":"Lencioni","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.clinimag.2026.110877_bb0400","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jpeds.2016.05.036","article-title":"Cerebral lipiodol embolism after lymphatic embolization for plastic bronchitis","volume":"176","author":"Kirschen","year":"2016","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.clinimag.2026.110877_bb0405","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1378\/chest.10-1591","article-title":"131I-labeled lipiodol-induced interstitial pneumonia","volume":"139","author":"Jouneau","year":"2011","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.clinimag.2026.110877_bb0410","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1097\/CCM.0000000000000307","article-title":"Lipiodol embolism following transarterial chemoembolization: an atypical case","volume":"42","author":"Taupin","year":"2014","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.clinimag.2026.110877_bb0415","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/028418519103200607","article-title":"Lung deposits of lipiodol in normal and cirrhotic rats","volume":"32","author":"Chiang","year":"1991","journal-title":"Acta Radiol"},{"issue":"4","key":"10.1016\/j.clinimag.2026.110877_bb0420","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1552-6569.2009.00380.x","article-title":"Cerebral embolism of iodized oil (lipiodol) after transcatheter arterial chemoembolization for hepatocellular carcinoma","volume":"19","author":"Kim","year":"2009","journal-title":"J Neuroimaging"},{"issue":"6","key":"10.1016\/j.clinimag.2026.110877_bb0425","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.rcl.2024.02.014","article-title":"Iodine and gadolinium contrast reactions: what is the risk and role of premedication, abbreviated protocols, prior history of reactions, and cross-reactivity?","volume":"62","author":"Mervak","year":"2024","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.clinimag.2026.110877_bb0430","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.23_suppl.65","article-title":"EMERALD-1: a phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization","author":"Kudo","year":"2024","journal-title":"J Clin Oncol"},{"issue":"10474","key":"10.1016\/j.clinimag.2026.110877_bb0435","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(24)02575-3","article-title":"Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study","volume":"405","author":"Kudo","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.clinimag.2026.110877_bb0440","author":"Malpass"},{"key":"10.1016\/j.clinimag.2026.110877_bb0450","author":"University of Chicago"},{"key":"10.1016\/j.clinimag.2026.110877_bb0455","article-title":"Efficacy of lipiodol embolization for chronic tendinopathy of the rotator cuff (ELECTRC): a randomized controlled trial","author":"Epelboym","year":"2025","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.clinimag.2026.110877_bb0460","author":"Epelboym"},{"key":"10.1016\/j.clinimag.2026.110877_bb0465","series-title":"A Comparison of Two Treatments to Reduce Prostate Size and Symptoms in Men With Benign Enlargement","author":"ISRCTN Registry","year":"2025"},{"issue":"3","key":"10.1016\/j.clinimag.2026.110877_bb0470","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/159101990200800304","article-title":"Glubran 2: a new acrylic glue for neuroradiological endovascular use","volume":"8","author":"Leonardi","year":"2002","journal-title":"Interv Neuroradiol"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707126001695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707126001695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:25:20Z","timestamp":1787919920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707126001695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":93,"alternative-id":["S0899707126001695"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2026.110877","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipiodol in embolization therapy: Evolution from a diagnostic to a therapeutic agent","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2026.110877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110877"}}